Fibulin-2 is essential for angiotensin II-induced myocardial fibrosis mediated by transforming growth factor (TGF)-β
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fibulin-2 is essential for angiotensin II-induced myocardial fibrosis mediated by transforming growth factor (TGF)-β
Authors
Keywords
-
Journal
LABORATORY INVESTIGATION
Volume 96, Issue 7, Pages 773-783
Publisher
Springer Nature
Online
2016-04-25
DOI
10.1038/labinvest.2016.52
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Enhanced Bioactive Myocardial Transforming Growth Factor-β in Advanced Human Heart Failure
- (2014) Shaukat Khan et al. CIRCULATION JOURNAL
- Fibulin-2 deficiency attenuates angiotensin II-induced cardiac hypertrophy by reducing transforming growth factor-β signalling
- (2013) Hangxiang Zhang et al. CLINICAL SCIENCE
- Therapeutic Cardiac‐Targeted Delivery of miR‐1 Reverses Pressure Overload–Induced Cardiac Hypertrophy and Attenuates Pathological Remodeling
- (2013) Ioannis Karakikes et al. Journal of the American Heart Association
- Matricellular Proteins in Cardiac Adaptation and Disease
- (2012) Nikolaos G. Frangogiannis PHYSIOLOGICAL REVIEWS
- Pivotal role of cardiomyocyte TGF-β signaling in the murine pathological response to sustained pressure overload
- (2011) Norimichi Koitabashi et al. JOURNAL OF CLINICAL INVESTIGATION
- Loss of fibulin-2 protects against progressive ventricular dysfunction after myocardial infarction
- (2011) Takeshi Tsuda et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Transforming Growth Factor β1 Oppositely Regulates the Hypertrophic and Contractile Response to β-Adrenergic Stimulation in the Heart
- (2011) Michael Huntgeburth et al. PLoS One
- Targeted inhibition of activin receptor-like kinase 5 signaling attenuates cardiac dysfunction following myocardial infarction
- (2010) Sih Min Tan et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Smad3 Mediates Cardiac Inflammation and Fibrosis in Angiotensin II–Induced Hypertensive Cardiac Remodeling
- (2010) Xiao R. Huang et al. HYPERTENSION
- Transforming growth factor (TGF)-β signaling in cardiac remodeling
- (2010) Marcin Dobaczewski et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Inhibition of transforming growth factor-β signaling induces left ventricular dilation and dysfunction in the pressure-overloaded heart
- (2009) Jason A. Lucas et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Transforming growth factor beta inhibition increases mortality and left ventricular dilatation after myocardial infarction
- (2008) Stefan Frantz et al. BASIC RESEARCH IN CARDIOLOGY
- Transforming Growth Factor-β Blockade Down-Regulates the Renin-Angiotensin System and Modifies Cardiac Remodeling after Myocardial Infarction
- (2008) Leigh J. Ellmers et al. ENDOCRINOLOGY
- Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure
- (2008) Norimichi Koitabashi et al. EUROPEAN JOURNAL OF HEART FAILURE
- Angiotensin II: A hormone involved in and contributing to pro-hypertrophic cardiac networks and target of anti-hypertrophic cross-talks
- (2008) K.-D. Schlüter et al. PHARMACOLOGY & THERAPEUTICS
- Atrial Natriuretic Peptide Inhibits Transforming Growth Factor β–Induced Smad Signaling and Myofibroblast Transformation in Mouse Cardiac Fibroblasts
- (2007) Peng Li et al. CIRCULATION RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now